NL-OMON53704尚未招募3 期
Pragmatic trial on the safety and tolerability of an optimized dose of rifampicin in tuberculosis patients - PORT: Pragmatic Optimized Rifampicin trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •The patient has a diagnosis of pulmonary tuberculosis according to the local
- •diagnostic criteria.
- •The patient is aged 18 years or older at the day of informed consent.
- •No known allergic reactions or toxicity to rifampicin in the past.
排除标准
- •Patient infected with a rifampicin-resistant strain of M. tuberculosis.
- •The patient has TB meningitis.
- •The patient is in a coma.
研究者
相似试验
进行中（未招募）
1 期
Pragmatic trial on the safety and tolerability of an optimized dose of rifampicin in tuberculosis patientsTuberculosisCTIS2023-509885-39-00Stichting Radboud University Medical Center130
进行中（未招募）
1 期
High dose rifampicin for tuberculosis, PORTMedDRA version: 20.0Level: PTClassification code 10037440Term: Pulmonary tuberculosisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 25.1Level: LLTClassification code 10087871Term: Drug-sensitive pulmonary tuberculosisSystem Organ Class: 10021881 - Infections and infestationsTuberculosisEUCTR2022-000632-27-DKRadboud University Medical Center164
进行中（未招募）
1 期
High dose rifampicin for tuberculosis, PORTTuberculosisEUCTR2022-000632-27-NLRadboud University Medical Center164
未知
1 期
Phase 1 Study of BMS-986148Solid tumorsJPRN-jRCT2080223357Bristol-Myers Squibb K.K.15
未知
1 期
Study of BMS-986012 in Subjects With Small Cell Lung CanerSmall Cell Lung CancerJPRN-jRCT2080223369Bristol-Myers Squibb K.K.18